COGENT BIOSCIENCES ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION (NDA) FOR BEZUCLASTINIB IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM)

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.